<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="159687">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01810094</url>
  </required_header>
  <id_info>
    <org_study_id>AAG-O-H-0910</org_study_id>
    <nct_id>NCT01810094</nct_id>
  </id_info>
  <brief_title>Minimally Invasive Reduction and Fixation of Thoracolumbar Fractures</brief_title>
  <acronym>FRIFIX</acronym>
  <official_title>Prospective Observational Study of Minimally Invasive Fixation of Thoracolumbar Fractures With the Fracture Fixation System S4, Performed With the Fracture Reduction Instrumentation FRI (FRIFIX)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aesculap AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aesculap AG</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Spinal injuries, such as vertebral fractures, often result in a significant instability of
      the spine and lead to acute or delayed neurological deficits. Depending on the type of
      injury there are various methods available to stabilize the spine. The proposed study should
      clarify whether the combined reduction and fixation with a minimally invasive approach can
      actually be done with the same precision as in a conventional approach. The primary endpoint
      of this investigation is the monosegmental anterior wedge angle (AWA), and its maintenance
      over the first 6 postoperative weeks. It is the aim of the study to gather key radiological,
      clinical and subjective patient outcome parameters for its patient population that will
      allow to compare the results to a historical group of patients. The study design is
      non-interventional, prospective, open,and multicentric.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">April 2015</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Anterior wedge angle (AWA)</measure>
    <time_frame>6 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood loss of the patient during surgery to stabilize the spine fracture</measure>
    <time_frame>intraoperative</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>OP duration</measure>
    <time_frame>intraoperative</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>Intraop and Postop</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS Spine Score</measure>
    <time_frame>3 days and 6 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS pain score</measure>
    <time_frame>3 days and 6 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>accompanying pain medication (or &quot;self medication&quot;)</measure>
    <time_frame>6 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction with operational results</measure>
    <time_frame>6 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>The patient is asked the question whether he is satisfied with the results of the operation, he has the choice between six answers: very satisfied, satisfied, partly satisfied, unsatisfied, no comment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>discharge</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Thoracic Fracture</condition>
  <condition>Lumbar Fracture</condition>
  <arm_group>
    <arm_group_label>Minimally invasive Approach</arm_group_label>
    <description>Patients with a thoracolumbar Fracture A3.1 to A 3.3 treated by fracture fixation by a minimally invasive approach</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fracture Fixation</intervention_name>
    <description>Thoracolumbar Fracture Fixation</description>
    <arm_group_label>Minimally invasive Approach</arm_group_label>
    <other_name>Fracture Fixation</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        adult patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Minimum age of the patients of 18 years

          -  Indication for operative treatment of fractures of the thoracic or lumbar spine

          -  Singular A3.1-3 fractures according to the AO classification system

          -  Declaration of consent in participation in this study and willingness to the
             treatment according to the study protocol

          -  Physical and mental ability to meet the clinical and radiological follow-up plan

        Exclusion Criteria:

          -  Additional severe trauma, that makes survey of the patient difficult or impossible
             influence the results of the fracture treatment significantly

          -  Additional trauma or fractures of the spine

          -  Other serious conditions complicating participation in the study

          -  Systemic or local infections

          -  Pregnancy or planned pregnancy

          -  Neurological deficits

          -  Severe blood coagulation disorders diagnosed preoperatively

          -  Intake of preoperatively anticoagulants

          -  Osteoporosis

          -  Bone metabolism disorders

          -  Laminectomy necessary during surgery results in exclusion of the patient either
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hans Goost, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum  Bonn</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrea Weiler, Dr.</last_name>
    <phone>+49-7461-95-2721</phone>
    <email>andrea.weiler@aesculap.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Norbert Pfeiff</last_name>
    <phone>+49-7461-95-1663</phone>
    <email>norbert.pfeiff@aesculap.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Vinzenz-Pallotti-Hospital</name>
      <address>
        <city>Bergisch Gladbach</city>
        <zip>51429</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gereon Schiffer, MD</last_name>
    </contact>
    <investigator>
      <last_name>Gereon Schiffer, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Annika Sayar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik Bonn, Abteilung für Unfallchirurgie</name>
      <address>
        <city>Bonn</city>
        <zip>53127</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kourosh Kabir, MD</last_name>
    </contact>
    <investigator>
      <last_name>Christoph Deborre, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kourosh Kabir, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik für Unfall-, Hand- und Wiederherstellungschirurgie, Universitätsklinik Köln</name>
      <address>
        <city>Köln</city>
        <zip>50924</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanouil Skouras, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Kourosh Zarghooni, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Emmanouil Souras, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kourosh Zarghooni, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jan Siewe, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Klaus Burkhart, PD MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christoph Faymonville, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Henning Kunter, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Timmo Koy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jan Bredow, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Johannes Oppermann</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christoph Deborre, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gregor Stein, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Abteilung für Orthopädie und Unfallchirurgie, Krankenhaus Wermelskirchen</name>
      <address>
        <city>Wermelskirchen</city>
        <zip>42929</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hans Goost, MD</last_name>
    </contact>
    <investigator>
      <last_name>Hans Goost, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 15, 2014</lastchanged_date>
  <firstreceived_date>February 26, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>thoracolumbar fracture</keyword>
  <keyword>fixation</keyword>
  <keyword>fixateur interne</keyword>
  <keyword>minimal invasive</keyword>
  <keyword>percutaneous</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fractures, Bone</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
